Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 1, Pages 44
Publisher
MDPI AG
Online
2020-12-31
DOI
10.3390/v13010044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
- (2020) Heshui Shi et al. LANCET INFECTIOUS DISEASES
- Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Fengxiang Song et al. RADIOLOGY
- Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia
- (2020) Feng Pan et al. RADIOLOGY
- Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
- (2020) Tao Ai et al. RADIOLOGY
- CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
- (2020) Michael Chung et al. RADIOLOGY
- Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019
- (2020) Cong Shen et al. Journal of Pharmaceutical Analysis
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography
- (2020) Kang Zhang et al. CELL
- Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
- (2020) Pierre Bost et al. CELL
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- The hallmarks of COVID-19 disease
- (2020) Daolin Tang et al. PLoS Pathogens
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
- (2020) Giuseppe Lippi et al. CLINICA CHIMICA ACTA
- Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis
- (2020) Marco Francone et al. EUROPEAN RADIOLOGY
- Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
- (2020) Mahnaz Ghaebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection
- (2020) Bikash R. Sahu et al. CLINICA CHIMICA ACTA
- The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- (2020) Jin-Yan Li et al. VIRUS RESEARCH
- Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
- (2020) Katie L. Flanagan et al. Frontiers in Immunology
- Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?
- (2015) Marc Meili et al. Expert Review of Respiratory Medicine
- Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies
- (2013) Yafang Huang et al. BRITISH JOURNAL OF GENERAL PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation